Article
Pathological complete response to gefitinib in a 10-year-old boy with EGFR-negative pulmonary mucoepidermoid carcinoma: a case report and literature review.
The clinical respiratory journal - 1 May 2017
Li Shaomei, Zhang Zhe, Tang Hong, He Zhen, Gao Yun, Ma Weiguo, Chang Yuxi, Wei Bing, Ma Jie, Liu Kangdong, Ma Zhiyong, Wang Qiming
Abstract excerpt
BACKGROUND AND AIMS: Pulmonary Mucoepidermoid carcinoma (MEC) accounts for 0.1-0.2% of all lung cancer. It occurred in the 3-78 years old, and 50% patients younger than 30. MEC has no standard treatment, but recently reports indicated MEC without epidermal growth factor receptor (EGFR) mutations sensitive to gefitinib. OBJECTIVES: To explore a new standard treatment strategy for MEC, after reviewed literature...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.